Active, Not Recruiting
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke - CV185-749
Updated: 17 November, 2022 | ClinicalTrials.gov
Print Friendly Summary
Trial Details
Phase
Gender(s)
Age Range
Active, Not Recruiting
Treatment Options
Inclusion Criteria: - Men and women at least 70 years of age who are new or established participants in the primary care practice - Willing to provide consent to participate in the study and to use personal health information to ascertain endpoints from the Center for Medicare & Medicaid Services (CMS) Medicare Claims Database and to access data from health records - Health insurance by Medicare Parts A & B (Medicare Fee-for-service) Exclusion Criteria: - Oral anticoagulation (OAC) for any indication at the time of enrollment - History of Atrial Fibrillation (AF) or Atrial Flutter (AFL) as documented in the participant's current medical problem list - Any condition the investigator considers a contraindication to OAC, e.g., bleeding that required medical attention or severe renal impairment - Any condition the investigator considers will prevent compliance with study instructions - Implanted cardiac devices (pacemakers, implantable cardiac defibrillators, or cardiac resynchronization therapy, and implantable loop recorders) - History of allergy to adhesive - Not able to wear the Zio®XT monitor or not able to apply the monitor by herself/himself or with the help of a caregiver Other protocol-defined inclusion/exclusion criteria could apply
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
